Spermatogenesis in mouse testicular organoids with testis-specific architecture, improved germ cell survival and testosterone production

Biofabrication. 2024 Aug 14;16(4). doi: 10.1088/1758-5090/ad618f.

Abstract

This study presents a biphasic approach to overcome the limitations of current testicular organoid (TO) cultures, including histological heterogeneity, germ cell loss and absence of spermatogenesis. Agarose microwells were utilized to create TOs from prepubertal C57BL/6 J testicular cells. First emphasis was on improving germ cell survival during the initial 2-week reorganization phase by comparingα-MEM + 10% knockout serum replacement (KSR) medium, known to support TO generation in mice, to three optimized media (1-3). Cell densities and culture dynamics were also tested to recreate histological resemblance to testes. After optimizing germ cell survival and cell organization, the effect of growth factors and immunomodulation through CD45+immune cell depletion or dexamethasone (DEX) supplementation were assessed for enhancing spermatogenesis during the subsequent differentiation phase. Testicular cells self-reorganized into organoids resembling the testicular anatomical unit, characterized by one tubule-like structure surrounded by interstitium. Media 1-3 proved superior for organoid growth during the reorganization phase, with TOs in medium 3 exhibiting germ cell numbers (7.4% ± 4.8%) comparable to controls (9.3% ± 5.3%). Additionally, 37% ± 30% demonstrated organized histology from 32 × 103cells under static conditions. Switching toα-MEM + 10% KSR during the differentiation phase increased formation efficiency to 85 ± 7%, along with elevated germ cell numbers, testosterone production (3.1 ± 0.9 ng ml-1) and generation ofγ-H2AX+spermatid-like cells (steps 8-11, 1.2% ± 2.2% of the total). Adding differentiation factors to theα-MEM increased spermatid-like cell numbers to 2.9% ± 5.9%, confirmed through positive staining for CREM, transition protein 1, and peanut agglutinin. Although, these remained diploid with irregular nuclear maturation. DEX supplementation had no additional effect, and immune cell depletion adversely impacted TO formation. The manipulability of TOs offers advantages in studying male infertility and exploring therapies, with scalability enabling high-throughput chemical screening and reducing animal usage in reproductive toxicity and drug discovery studies.

Keywords: in vitro spermatogenesis; male infertility; reproductive toxicity; spermatogonial stem cells; testicular organoids.

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cell Survival* / drug effects
  • Dexamethasone / pharmacology
  • Germ Cells / cytology
  • Germ Cells / drug effects
  • Germ Cells / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Organoids* / cytology
  • Organoids* / drug effects
  • Organoids* / metabolism
  • Spermatogenesis* / drug effects
  • Testis* / cytology
  • Testis* / drug effects
  • Testis* / metabolism
  • Testosterone* / pharmacology

Substances

  • Testosterone
  • Dexamethasone